Psychedelic research is gaining momentum, and Robin Carhart-Harris with his team at Imperial College, London is one of the most prolific groups pushing the science forward. In May 2021, the New England Journal of Medicine published their head to head depression study of an SSRI vs. psilocybin. In today’s episode, we are joined by a pioneering neuroscientist, Dr. Robin Carhart-Harris. We dive into conversations around the effects of psychedelics on brain networks, the nuances of ego, self, and other, and exciting developments within the research. Show notes: Revealing the depths of the unconscious mind - 02:49 The default mode network and what role it plays in mental health - 11:35 What the future holds for psychedelics and psychotherapy - 18:31 Where are we in psilocybin and clinical research? - 22:41 Understanding what the psychedelic experience is - 28:37 Dissociation, presence, and how psychedelics ties in - 35:13 To learn more about Dr. Robin Carhart-Harris: https://time.com/collection/time100-next-2021/5937720/robin-carhart-harris/ https://www.imperial.ac.uk/people/r.carhart-harris https://scholar.google.ca/citations?user=7_MD_w0AAAAJ&hl=en *** How you can help others in a big way... If you enjoy the Higher Practice Podcast, please leave a quick review on the Apple Podcast app. It makes a big difference in getting the word out to other people who will benefit from this podcast. Simply, click on the show on your podcast app>scroll down to the bottom of all the episodes>in the ratings and reviews section tap stars to rate>click write a review. Want more? For show notes and more information, visit https://psychiatryinstitute.com/podcast/ Sign up for our newsletter and to receive ongoing information for optimal mental health: email.psychiatryinstitute.com If you’re a provider visit https://psychiatryinstitute.com/ If you’re interested in patient care visit: www.psychiatrycenters.com For provider education reach out to: info@psychiatryinstitute.com For patient care reach out to: info@psychiatrycenters.com